The syrup Salmolin-L contains Levosalbutamol and is made by The ACME Laboratories Ltd. Salmolin-L 1 mg/5 ml syrup is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children with reversible obstructive airway disease.
There are 41 brands of Levosalbutamol listed in Bangladesh. 24 of them have a lower unit price than Salmolin-L. The lowest listed price is Purilin 1 mg Tablet at ৳ 0.9 per unit.
What is Salmolin-L 1 mg/5 ml Syrup?
Salmolin-L 1 mg/5 ml is a syrup product of The ACME Laboratories Ltd. that contains Levosalbutamol. It belongs to a group of medicines that act on the beta receptors in the airways. The supplied information describes Levosalbutamol nebuliser solution and inhaler for treating or preventing bronchospasm in adults, adolescents and children with reversible obstructive airway disease. Whether it suits you is a decision for your doctor.
Uses of Salmolin-L
Salmolin-L 1 mg/5 ml syrup is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children with reversible obstructive airway disease. Only a doctor can decide if it is right for you or your child. Salmolin-L is used to treat or prevent bronchospasm in adults, adolescents, and children who have reversible obstructive airway disease. Whether it suits a particular person, and how it fits with other asthma or airway medicines, is for the doctor to decide.
How to use Salmolin-L
If a dose is missed or breathing gets worse, contact a healthcare professional. Salmolin-L is taken by mouth. Measure the liquid with the cap or spoon that comes with the pack. Take Salmolin-L syrup exactly as your doctor prescribes. Do not change the amount or stop it without medical advice. Do not change the amount or stop it without asking the doctor.
Side effects of Salmolin-L
Some people may feel nervous, get a headache, feel dizzy, tired, or have trouble sleeping. Some people report nervousness, headache, dizziness, tiredness or sleeplessness. If you notice any side effect, tell your doctor. Tell your doctor if you have any troublesome effects.
Safety and precautions
Use in pregnancy only if the doctor judges the benefit to outweigh the risk to the fetus. Ask the doctor before use in these situations. This medicine should be used with caution in people who react strongly to sympathomimetic amines. Tell your doctor about all the other medicines you take.
Frequently asked questions
What is Salmolin-L used for?
Salmolin-L 1 mg/5 ml syrup is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children with reversible obstructive airway disease. Only a doctor can decide if it is right for you or your child.
How is Salmolin-L used?
If a dose is missed or breathing gets worse, contact a healthcare professional. Salmolin-L is taken by mouth.
Can Salmolin-L cause side effects?
Some people may feel nervous, get a headache, feel dizzy, tired, or have trouble sleeping. Some people report nervousness, headache, dizziness, tiredness or sleeplessness.
Levosalbutamol Nebuliser Solution or Inhaler is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children with reversible obstructive airway disease.
Pharmacology
Levosalbutamol Nebuliser Solution is a sterile, clear, colorless, preservative-free solution of the hydrochloride salt of Levosalbutamol, the (R)-enantiomer of the drug substance racemic salbutamol. Levosalbutamol Hydrochloride is a relatively selective β2 adrenergic receptor agonist.
Activation of β2 adrenergic receptors on airway smooth muscle leads to the activation of adenylcyclase and to an increase in the intracellular concentration of cyclic AMP. This increase in cAMP leads to the activation of protein kinase A, which inhibits the phosphorylation of myosin and lowers intracellular ionic calcium concentrations, resulting in relaxation. Levosalbutamol relaxes the smooth muscles of all airways, from the trachea to the terminal bronchioles. Levosalbutamol acts as a functional antagonist to relax the airway irrespective of the spasmogen involved, thus protecting against all bronchoconstrictor.
Dosage & Administration
Nebuliser Solution: This Nebuliser Solutions supplied in unit-dose ampoules and requires no dilution before administration by nebulization.
Children (6 months-11 years): The recommended dosage is 0.31 mg administered three times a day, by nebulization. Routine dosing should not exceed 0.63 mg three times a day.
Adults and Adolescents above 12 years old: The recommended starting dosage is 0.63 mg administered three to four times a day, every 6 to 8 hours, by nebulization.
Patients 12 years of age and older: With more severe asthma or patients who do not respond adequately: 0.63 mg of Levosalbutamol Nebuliser Solution may benefit from a dosage of 1.25 mg three times a day.
Inhaler: You should take your Levosalbutamol Inhaler as needed for an asthma attack at any time of day, with or without food, by taking 1-2 puffs up to 4 times daily and no more than 8 puffs in 24 hours. If you are using your Levosalbutamol Inhaler more than 3-4 times a week this may indicate that your asthma is not well controlled and you may need to review your medication. You can also use your Levosalbutamol Inhaler to prevent allergy or exercise induced asthma by taking 2 puffs 15 minutes before exercise or exposure to a known allergen.
Interaction
Other short-acting sympathomimetic aerosol bronchodilators or epinephrine should be used with caution with Levosalbutamol. If additional adrenergic drugs are to be administered by any route, they should be used with caution to avoid deleterious cardiovascular effects.
Beta-blockers: Beta-adrenergic receptor blocking agents not only block the pulmonary effect of beta-agonists such as Levosalbutamol Nebuliser Solution or Inhaler, but may also produce severe bronchospasm in asthmatic patients. However, under certain circumstances, e.g. prophylaxis after myocardial infarction, there may be no acceptable alternatives to the use of beta-adrenergic blocking agents in patients with asthma. In this setting, cardio selective beta-blockers could be considered with caution.
Diuretics: The ECG changes and/or hypokalemia that may result from the administration of non-potassium sparing diuretics can be acutely worsened by beta-agonists when the recommended dose of the beta-agonist is exceeded.
Digoxin: It is necessary to carefully evaluate the serum digoxin levels in patients who are currently receiving digoxin and Levosalbutamol Nebuliser Solution or Inhaler.
Monoamine Oxidase Inhibitors or Tricyclic Antidepressants: Levosalbutamol Nebuliser Solution or Inhaler should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants, or within 2 weeks of discontinuation of such agents.
Side Effects
Potentially serious hypokalaemia may result from beta 2 - agonist therapy. This effect may be potentiated by hypoxia. Other side effects such as palpitation, fine tremors of the skeletal muscle (particularly the hand) and muscle cramps may occur. In few cases nervousness, headache, dizziness, fatigue and sleeplessness have also been reported.
Pregnancy & Lactation
Pregnancy: There are no adequate and well-controlled studies of Levosalbutamol Nebuliser Solution in pregnant women. Levosalbutamol Solution should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Lactation: It is not known whether Levosalbutamol is excreted in human milk. Caution should be exercised when Levosalbutamol Nebuliser Solution is administered to a nursing woman.
Precautions & Warnings
Levosalbutamol Hydrochloride, like all sympathomimetic amines, should be used with caution in patients with cardiovascular disorders, especially coronary insufficiency, hypertension, and cardiac arrhythmias; in patients with convulsive disorders, hyperthyroidism, or diabetes mellitus; and in patients who are unusually responsive to sympathomimetic amines. Levosalbutamol Nebuliser Solution or Inhaler must not be injected.
Overdose Effects
The expected symptoms with over dosage are those of excessive beta-adrenergic receptor stimulation and/or occurrence or exaggeration of any of the symptoms listed under side effects. Treatment consists of discontinuation of Levosalbutamol Nebuliser Solution or Inhaler together with appropriate symptomatic therapy. The judicious use of a cardioselective beta-receptor blocker may be considered.
Storage Conditions
Store below 25°C. Protect from light. Do not refrigerate.
Alternative brands of Levosalbutamol
Other brands with the same generic name, cheapest first.